213 related articles for article (PubMed ID: 38625653)
21. Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T.
Ahrar K; Ahrar JU; Javadi S; Pan L; Milton DR; Wood CG; Matin SF; Stafford RJ
Invest Radiol; 2013 Jun; 48(6):437-44. PubMed ID: 23511191
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous ablation techniques for renal cell carcinoma: current status and future trends.
Filippiadis D; Mauri G; Marra P; Charalampopoulos G; Gennaro N; De Cobelli F
Int J Hyperthermia; 2019 Oct; 36(2):21-30. PubMed ID: 31537160
[TBL] [Abstract][Full Text] [Related]
23. [Indications for ablative treatment in kidney cancer in the elderly].
Froger L; Neuzillet Y; Lebret T
Prog Urol; 2012 Dec; 22(16):1004-9. PubMed ID: 23178096
[TBL] [Abstract][Full Text] [Related]
24. Impact of short warm ischemic time on longitudinal kidney function and survival rate after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease stage III: A multi-institutional propensity score-matched study.
Chung JS; Hong SK; Lee SC; Jeong CW; Kwak C; Kim HH; Hong SH; Kim YJ; Kang SH; Chung J; Kwon TG; Hwang EC; Byun SS
Eur J Surg Oncol; 2021 Feb; 47(2):470-476. PubMed ID: 32631709
[TBL] [Abstract][Full Text] [Related]
25. Thermal ablation of the small renal mass: a critical analysis of current literature.
Mershon JP; Tuong MN; Schenkman NS
Minerva Urol Nefrol; 2020 Apr; 72(2):123-134. PubMed ID: 31833721
[TBL] [Abstract][Full Text] [Related]
26. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
27. Asian Conference on Tumor Ablation guidelines for renal cell carcinoma.
Park BK; Shen SH; Fujimori M; Wang Y
Investig Clin Urol; 2021 Jul; 62(4):378-388. PubMed ID: 34190433
[TBL] [Abstract][Full Text] [Related]
28. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
El Dib R; Touma NJ; Kapoor A
BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
[TBL] [Abstract][Full Text] [Related]
29. Renal functional outcomes after cryoablation of small renal masses.
Malcolm JB; Logan JE; Given RW; Lance R; Vingan H; Shaves SC; Fabrizio M
J Endourol; 2010 Mar; 24(3):479-82. PubMed ID: 19839780
[TBL] [Abstract][Full Text] [Related]
30. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
[TBL] [Abstract][Full Text] [Related]
31. Personalized Treatment for Small Renal Tumors: Decision Analysis of Competing Causes of Mortality.
Kang SK; Huang WC; Elkin EB; Pandharipande PV; Braithwaite RS
Radiology; 2019 Mar; 290(3):732-743. PubMed ID: 30644815
[TBL] [Abstract][Full Text] [Related]
32. [Ultrasound-guided percutaneous cryoablation of renal tumors].
Enikeev DV; Glybochko PV; Alyaev YG; Rapoport LM; Amosov AV; Alekseeva TM; Enikeev ME; Tsarichenko DG; Chinenov DV; Kozmin LD; Dzhalaev ZK; Taratkin MS
Urologiia; 2017 Jul; (3):68-73. PubMed ID: 28845941
[TBL] [Abstract][Full Text] [Related]
33. Chronic Kidney Disease Is More Common in Locally Advanced Renal Cell Carcinoma.
Dey S; Hamilton Z; Noyes SL; Tobert CM; Keeley J; Derweesh IH; Lane BR
Urology; 2017 Jul; 105():101-107. PubMed ID: 28365357
[TBL] [Abstract][Full Text] [Related]
34. Microwave ablation of renal tumors: A narrative review of technical considerations and clinical results.
Cornelis FH; Marcelin C; Bernhard JC
Diagn Interv Imaging; 2017 Apr; 98(4):287-297. PubMed ID: 28011104
[TBL] [Abstract][Full Text] [Related]
35. The current status of thermal ablation in the management of T1b renal masses.
Welch BT; Shah PH; Thompson RH; Atwell TD
Int J Hyperthermia; 2019 Oct; 36(2):31-36. PubMed ID: 31537163
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
[TBL] [Abstract][Full Text] [Related]
37. Update on ablative therapies of renal tumors.
D'Andrea D; Shariat SF; Klatte T
Curr Opin Urol; 2016 Sep; 26(5):410-6. PubMed ID: 27214581
[TBL] [Abstract][Full Text] [Related]
38. Preoperative Chronic Kidney Disease Status is an Independent Prognostic Factor in Patients with Renal Cell Carcinoma.
Kim YW; Kim WT; Yun SJ; Lee SC; Kim WJ; Ha YS; Park YH; Kang SH; Hong SH; Kwon TG; Byun SS; Kwak C; Kim YJ
Ann Surg Oncol; 2015 Nov; 22(12):4098-103. PubMed ID: 25851339
[TBL] [Abstract][Full Text] [Related]
39. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
[TBL] [Abstract][Full Text] [Related]
40. Partial versus Radical Nephrectomy for T1-T2 Renal Cell Carcinoma in Patients with Chronic Kidney Disease Stage III: a Multiinstitutional Analysis of Kidney Function and Survival Rate.
Chung JS; Son NH; Lee SE; Hong SK; Jeong CW; Kwak C; Kim HH; Hong SH; Kim YJ; Kang SH; Chung J; Kwon TG; Hwang EC; Byun SS
J Korean Med Sci; 2018 Oct; 33(43):e277. PubMed ID: 30344463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
